ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS

Figueiredo C, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nüsslein H, Alten R, Henes JC, Krueger K, Rech J, Schett G (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 75 2

Pages Range: 961-962

Authors with CRIS profile

Matthias Englbrecht Lehrstuhl für Innere Medizin III Bernhard Manger Professur für Rheumatologie und Klinische Immunologie Karin Manger Medizinische Fakultät Hubert Nüsslein Medizinische Fakultät Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Praxiszentrum St. Bonifatius DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Universitätsklinikum Tübingen DE Germany (DE) Universitätsklinikum Freiburg DE Germany (DE) Medizinische Universität Wien AT Austria (AT) Julius-Maximilians-Universität Würzburg DE Germany (DE) Asklepios Kliniken DE Germany (DE) Medias Klinikum DE Germany (DE) ORGENTEC Diagnostika GmbH DE Germany (DE)

How to cite

APA:

Figueiredo, C., Bang, H., Cobra, J.F., Englbrecht, M., Hueber, A.J., Haschka, J.,... Schett, G. (2016). ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS. (pp. 961-962).

MLA:

Figueiredo, C., et al. "ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS." 2016. 961-962.

BibTeX: Download